Lamotrigine For Suspension(Shanghai Okoyuan Pharma)

拉莫三嗪干混悬剂(上海奥科远制药)

Report date: 2025/07/28 15:05:48

Base Information

Drug NameLamotrigine For Suspension(Shanghai Okoyuan Pharma)
Drug Alias NameLamotriginum拉莫三秦Lamactil拉米克妥Lamictin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A